|
Hab einfach den alten Thread ersetzt weils zu unübersichtlich wurde . Soligenix (SNGX) Marktkap: $50 Million Cash: $8 Million (ausreichend bis anfang 2021) Kurs: $1.89 Aktienanzahl: 26.6 M Pipeline https://www.soligenix.com/pipeline-programs/ Neue Präsentation http://ir.soligenix.com/download/Soligenix+Corporate+Present… SNGX: Q&A on COVID-19 Vaccine Candidate CiVax\u2122… https://finance.yahoo.com/news/sngx-q-covid-19-vaccine-09390… As a reminder, following the positive topline data presented by the company for SGX-301 in CTCL, we continue to anticipate Phase 3 data for SGX-942 in oral mucositis in the fourth quarter of 2020. The company will also be joining the Russell Microcap Index effective June 29th, 2020, which should help to increase visibility within the investment community. Our current valuation is $12 per share. |
|
| aus der Diskussion: | SNGX (MKap ) Covid 19 Vaccine /3x Phase 3 Programme |
| Autor (Datum des Eintrages): | Biohero (25.06.20 20:38:33) |
| Beitrag: | 1 von 154 (ID:64184608) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |